1. A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
    Rabia Bilge Özgül Özdemir et al, 2016, Annals of Diagnostic Pathology CrossRef
  2. Inferring human miRNA functional similarity based on gene ontology annotations
    Jiawei Luo et al, 2016 CrossRef
  3. miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.
    Furong Wei et al, 2016, Cell Mol Neurobiol CrossRef
  4. Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer
    Xiaoqian Jing et al, 2016 CrossRef
  5. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zefeng Zhang et al, 2016, Int J Mol Med CrossRef
  6. CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells
    Soo Young Lee et al, 2017 CrossRef
  7. Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy
    Yongqiang Zhan et al, 2016 CrossRef
  8. The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma
    Yumin Chung et al, 2018, J Pathol Transl Med CrossRef
  9. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
    Takayoshi Shirasaki et al, 2018, Sci Rep CrossRef
  10. Cancer Stem Cells in Metastasis Therapy
    Esra Aydemir Çoban et al, 2018 CrossRef
  11. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    Ramón Cantero-Cid et al, 2018, BMC Cancer CrossRef
  12. Demystifying the Differences Between Tumor-Initiating Cells and Cancer Stem Cells in Colon Cancer
    Priya Chatterji et al, 2018, Curr Colorectal Cancer Rep CrossRef
  13. Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
    Gui-Min Wen et al, 2018, Stem Cell Rev and Rep CrossRef
  14. Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines
    Wittaya Suwakulsiri et al, 2018, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef
  15. Cancer stem cell impact on clinical oncology
    Mariel E Toledo-Guzmán et al, 2018, WJSC CrossRef
  16. Effect of resveratrol on drug resistance in colon cancer chemotherapy
    Lu Huang et al, 2019, RSC Adv. CrossRef
  17. Stem Cell Markers in Colon Cancer
    Miana Gabriela Pop, 2019 CrossRef
  18. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200
    Yang-Hsiang Lin et al, 2018 CrossRef
  19. CD44 epithelial isoform inversely associates with invasive characteristics of colorectal cancer
    Asieh Sadeghi et al, 2019, Biomarkers in Medicine CrossRef
  20. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma
    Giacomo Lettini et al, 2016, Cell Death Differ CrossRef
  21. The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
    Zhenpeng Wang et al, 2019, Front. Oncol. CrossRef
  22. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
    Xintao Li et al, 2015, Sci Rep CrossRef
  23. IMMUNE PHENOTYPING OF FREE TUMOUR CELLS FOR EARLY DIAGNOSIS OF PERITONEAL CARCINOMATOSIS IN COLORECTAL CANCER
    Yu. A. Shelygin et al, 2019, Koloproktologiâ CrossRef
  24. Cancer stem cells in human digestive tract malignancies
    Fatemeh B. Rassouli et al, 2016, Tumor Biol. CrossRef
  25. Identification and Characterization of CD133pos Subpopulation Cells From a Human Laryngeal Cancer Cell Line
    Hai-ou Qiu et al, 2016, Med Sci Monit CrossRef
  26. Cancer Stem Cells
    Haseeb Zubair et al, 2016 CrossRef
  27. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis
    Hyuk Hur et al, 2016, Diseases of the Colon & Rectum CrossRef
  28. Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
    Maria V. Bogachek et al, 2016, Stem Cell Reports CrossRef
  29. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
    S M Riajul Wahab et al, 2017, Clin Colorectal Cancer CrossRef
  30. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
    Zohreh Jahanafrooz et al, 2019, J Cell Physiol CrossRef
  31. Triptolide inhibits CD133 + /CD44 + colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial‐mesenchymal transition via downregulating expressions of snail, slug, and twist
    Eda Acikgoz et al, 2020, J Cell Biochem CrossRef
  32. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact
    Ryouichi Tsunedomi et al, 2020, Surg Today CrossRef
  33. Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
    Christine Koulis et al, 2020, Cancers CrossRef
  34. Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
    Said Abdullah Khelwatty et al, 2019, Oncotarget CrossRef
  35. Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
    Jun Hu et al, 2017, Oncotarget CrossRef
  36. CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
    Yang Zhao et al, 2016, Oncotarget CrossRef
  37. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
    Pu Xia et al, 2016, Oncotarget CrossRef
  38. Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer
    Jin-Yong Zhou et al, 2016, Oncotarget CrossRef
  39. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells
    J. Chen et al, 2020, Braz J Med Biol Res CrossRef
  40. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer
    Ji Young Chang et al, 2020, Yonsei Med J CrossRef
  41. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia
    Brett S. Walker et al, 2020, World J Surg CrossRef
  42. BNIPL‑2 expression is correlated with the prognosis and regulates the proliferation of colorectal cancer through CD44
    Lei Gao et al, 2019, Mol Med Report CrossRef

  43. Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis


    Xiaoyu Wu et al, 2020, OTT CrossRef
  44. Curcumin may be a potential adjuvant treatment drug for colon cancer by targeting CD44
    Xu Fan et al, 2020, International Immunopharmacology CrossRef
  45. RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells.
    Xiaodong Yan et al, 2020, Cancer Cell Int CrossRef
  46. Cancer Stem Cells in Patient Survival and Therapies in Cancer
    Ying Yang et al, 2020 CrossRef
  47. Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp
    O. Crende et al, 2020, Biology CrossRef
  48. Signature mRNA markers in extracellular vesicles for the accurate diagnosis of colorectal cancer
    Byung Seok Cha et al, 2020, J Biol Eng CrossRef
  49. Targeting stemness of cancer stem cells to fight colorectal cancers
    Lei Du et al, 2021, Seminars in Cancer Biology CrossRef
  50. RUNX2 as a promising therapeutic target for malignant tumors
    Weizhu Zhao et al, 2021, CMAR CrossRef
  51. CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations
    Mohammad Mahmoudi Gomari et al, 2021, Mutation Research/Reviews in Mutation Research CrossRef
  52. Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer
    Tiantian Tan et al, 2021, Asian Journal of Pharmaceutical Sciences CrossRef
  53. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis
    Kevin Dzobo et al, 2021, OMICS: A Journal of Integrative Biology CrossRef
  54. Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients
    Octav Ginghină et al, 2021, Materials CrossRef
  55. RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls
    Namjoo Kim et al, 2021, Funct Integr Genomics CrossRef
  56. SMAR1 Suppresses the Cancer Stem Cell Population via hTERT Repression in Colorectal Cancer Cells
    Apoorva Parulekar et al, 2021, The International Journal of Biochemistry & Cell Biology CrossRef
  57. CDC25A is Strongly Associated with Colorectal Cancer Stem Cells and Poor Clinical Outcome of Patients
    Hamed Manoochehri et al, 2021, Gene Reports CrossRef
  58. Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer
    Mehran Pashirzad et al, 2022, Process Biochemistry CrossRef
  59. GTSE1 promotes tumor growth and metastasis by attenuating of KLF4 expression in clear cell renal cell carcinoma
    Weihao Chen et al, 2022, Lab Invest CrossRef
  60. Therapeutic Applications of the CRISPR-Cas System
    Kyungmin Kang et al, 2022, Bioengineering CrossRef
  61. Assessing Putative Markers of Colorectal Cancer Stem Cells: From Colonoscopy to Gene Expression Profiling
    Irina Florina Cherciu Harbiyeli et al, 2022, Diagnostics CrossRef
  62. Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer
    Yue Zhou et al, 2022, Clin Med Insights Oncol CrossRef
  63. A rapid high throughput bioprinted colorectal cancer spheroid platform for in vitro drug- and radiation-response
    Peter A Johnson et al, 2023, Biofabrication CrossRef
  64. New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
    Pina Ziranu et al, 2023, Cancers CrossRef
  65. Tissue-specific cancer stem/progenitor cells: Therapeutic implications.
    Amani Yehya et al, 2023, World J Stem Cells CrossRef
  66. GART Functions as a Novel Methyltransferase in the RUVBL1/β‐Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer
    Chao Tang et al, 2023, Advanced Science CrossRef
  67. Dermatan Sulfate/Chitosan Nanoparticles Loaded with an Anti‐Inflammatory Peptide Increase the Response of Human Colorectal Cancer Cells to 5‐Fluorouracil
    Agustín Blachman et al, 2023, Macromolecular Bioscience CrossRef
  68. Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells
    Fangzhou Li et al, 2024, Gene CrossRef
  69. Silencing LY6D Expression Inhibits Colon Cancer in Xenograft Mice and Regulates Colon Cancer Stem Cells’ Proliferation, Stemness, Invasion, and Apoptosis via the MAPK Pathway
    Jinyue Duan et al, 2023, Molecules CrossRef
  70. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
    Qi Zhao et al, 2024, Exp Hematol Oncol CrossRef
  71. A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer
    Mario Ortega Duran et al, 2024, Cells CrossRef
  72. Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs
    Amir Gholamzad et al, 2024, Pathology - Research and Practice CrossRef
  73. Cancer Stem Cells from Definition to Detection and Targeted Drugs
    Barbara Ruszkowska-Ciastek et al, 2024, IJMS CrossRef
  74. Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer
    Dorothy Bhattacharjya et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  75. MicroRNA-513b-5p inhibits epithelial mesenchymal transition of colon cancer stem cells through IL-6/STAT3 signaling pathway
    Zefeng Zhang et al, 2024, Discov Onc CrossRef
  76. Cellular Systems for Colorectal Stem Cancer Cell Research
    Tatyana A. Grigoreva et al, 2025, Cells CrossRef